세계의 호흡기세포융합바이러스(RSV) 진단 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2030년)

The global demand for Respiratory Syncytial Virus Diagnostics Market is presumed to reach the market size of nearly USD 2171.05 MN by 2030 from USD 998.2 MN in 2022 with a CAGR of 10.2% under the study period 2023 - 2030.

Respiratory syncytial virus (RSV) diagnostics refer to the various tests and methods used to detect and identify respiratory syncytial virus, a common viral pathogen that primarily affects the respiratory system. The virus is a major cause of respiratory tract infections in infants, young children, and older adults, and it can lead to conditions ranging from mild cold-like symptoms to severe respiratory illness, especially in vulnerable populations. Accurate and timely diagnosis of RSV is crucial for appropriate patient management and infection control.

MARKET DYNAMICS:

The Respiratory Syncytial Virus (RSV) diagnostics market is experiencing growth driven by several key factors. RSV is a prevalent respiratory virus that can cause severe illness, particularly in infants, the elderly, and individuals with weakened immune systems. This prevalence, coupled with seasonal outbreaks, underscores the need for accurate and timely diagnostics. Advancements in diagnostic technology, including molecular assays like PCR and point-of-care testing (POCT), have enhanced the sensitivity and speed of RSV detection, making diagnostics more efficient and accessible. The availability of rapid POCTs is particularly valuable in clinical settings, reducing the reliance on complex laboratory testing. Increased awareness of RSV's impact, especially among healthcare professionals, has contributed to greater consideration of RSV testing, particularly in pediatric and geriatric care. Public health preparedness and surveillance also rely on RSV diagnostics to track and respond to outbreaks. Additionally, the aging global population and the globalization of travel have raised the risk of severe RSV infections in various regions, further driving the demand for diagnostics. As innovative diagnostic technologies continue to develop and awareness of RSV's severity grows, the market for RSV diagnostics is expected to expand further, ensuring early identification and intervention for this significant respiratory virus.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of respiratory syncytial virus diagnostics. The growth and trends of respiratory syncytial virus diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the respiratory syncytial virus diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Direct Fluorescent Antibody (Dfa) Method
• Rapid Antigen Diagnostic Test (Radt)
• Molecular Diagnostics
• Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc))
• Diagnostic Imaging
• Gel Microdroplets
• Flow Cytometry
• Others

By End-Use

• Hospitals
• Laboratory
• Clinics
• Homecare

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Respiratory Syncytial Virus Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Respiratory Syncytial Virus Diagnostics market include Becton, Dickinson, and Company, Novartis AG, Abbott, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., BIOMERIEUX, DiaSorin SpA, Merck KGaA, Quidel Corp., Coris BioConcept, Siemens Healthcare SA, Quest Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By End-Use
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Direct Fluorescent Antibody (Dfa) Method Historic and Forecast Sales by Regions
• 5.5 Rapid Antigen Diagnostic Test (Radt) Historic and Forecast Sales by Regions
• 5.6 Molecular Diagnostics Historic and Forecast Sales by Regions
• 5.7 Chromatographic Immunoassay (Gravity Driven Test, Oligo Chromatography (Oc)) Historic and Forecast Sales by Regions
• 5.8 Diagnostic Imaging Historic and Forecast Sales by Regions
• 5.9 Gel Microdroplets Historic and Forecast Sales by Regions
• 5.10. Flow Cytometry Historic and Forecast Sales by Regions
• 5.11 Others Historic and Forecast Sales by Regions

6 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY END-USE

• 6.1 Overview by End-Use
• 6.2 Historical and Forecast Data
• 6.3 Analysis by End-Use
• 6.4 Hospitals Historic and Forecast Sales by Regions
• 6.5 Laboratory Historic and Forecast Sales by Regions
• 6.6 Clinics Historic and Forecast Sales by Regions
• 6.7 Homecare Historic and Forecast Sales by Regions

7 . GLOBAL RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS COMPANIES

• 8.1. Respiratory Syncytial Virus Diagnostics Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF RESPIRATORY SYNCYTIAL VIRUS DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Becton
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Dickinson and Company
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Novartis AG
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Abbott
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Ortho Clinical Diagnostics
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Thermo Fisher Scientific Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Bio-Rad Laboratories Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. F. Hoffmann-La Roche Ltd.
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. BIOMERIEUX
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. DiaSorin SpA
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments
• 9.13. Merck KGaA
  • 9.13.1. Company Overview
  • 9.13.2. Company Revenue
  • 9.13.3. Products
  • 9.13.4. Recent Developments
• 9.14. Quidel Corp.
  • 9.14.1. Company Overview
  • 9.14.2. Company Revenue
  • 9.14.3. Products
  • 9.14.4. Recent Developments
• 9.15. Coris BioConcept
  • 9.15.1. Company Overview
  • 9.15.2. Company Revenue
  • 9.15.3. Products
  • 9.15.4. Recent Developments
• 9.16. Siemens Healthcare SA
  • 9.16.1. Company Overview
  • 9.16.2. Company Revenue
  • 9.16.3. Products
  • 9.16.4. Recent Developments
• 9.17. Quest Diagnostics Inc.
  • 9.17.1. Company Overview
  • 9.17.2. Company Revenue
  • 9.17.3. Products
  • 9.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies